HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Assia Shisheva Selected Research

phosphatidylinositol 3,5-diphosphate

12/2019Severe Consequences of SAC3/FIG4 Phosphatase Deficiency to Phosphoinositides in Patients with Charcot-Marie-Tooth Disease Type-4J.
10/2014Host PI(3,5)P2 activity is required for Plasmodium berghei growth during liver stage infection.
6/2008PIKfyve: Partners, significance, debates and paradoxes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Assia Shisheva Research Topics

Disease

3Neoplasms (Cancer)
11/2019 - 10/2007
3Insulin Resistance
06/2016 - 09/2009
1Polyneuropathies (Polyneuropathy)
12/2019
1Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy)
12/2019
1Neoplasm Metastasis (Metastasis)
01/2019
1Prostatic Neoplasms (Prostate Cancer)
01/2019
1Glucose Intolerance
06/2016
1Type 1 Spherocytosis
11/2015
1Neurodegenerative Diseases (Neurodegenerative Disease)
11/2015
1Protein Deficiency
11/2015
1Synucleinopathies
11/2015
1Infections
10/2014
1Osteosarcoma (Osteogenic Sarcoma)
03/2014
1Down Syndrome (Down's Syndrome)
03/2014
1Alzheimer Disease (Alzheimer's Disease)
03/2014
1Breast Neoplasms (Breast Cancer)
10/2013
1Triple Negative Breast Neoplasms
10/2013
1Hyperinsulinism (Hyperinsulinemia)
07/2013
1Body Weight (Weight, Body)
07/2013
1Perinatal Death
06/2008
1Urinary Bladder Neoplasms (Bladder Cancer)
10/2007
1Carcinoma (Carcinomatosis)
10/2007
1Carcinogenesis
10/2007
1Congenital Structural Myopathies (Centronuclear Myopathy)
04/2004
1Shock
09/2003

Drug/Important Bio-Agent (IBA)

4Phosphoric Monoester Hydrolases (Phosphatases)IBA
12/2019 - 09/2009
3phosphatidylinositol 3,5-diphosphateIBA
12/2019 - 06/2008
3LipidsIBA
01/2019 - 10/2007
3Proteins (Proteins, Gene)FDA Link
11/2015 - 06/2008
3EnzymesIBA
10/2013 - 09/2003
2Phosphatidylinositols (Phosphatidylinositol)IBA
12/2019 - 04/2004
2Glucose (Dextrose)FDA LinkGeneric
06/2016 - 07/2013
2Phosphotransferases (Kinase)IBA
03/2014 - 10/2007
2Insulin (Novolin)FDA Link
09/2009 - 09/2003
1phosphatidylinositol 3-phosphateIBA
12/2019
1phosphatidylinositol 5-phosphateIBA
12/2019
1apilimodIBA
11/2019
1Drug CombinationsIBA
11/2019
1AndrogensIBA
01/2019
1ChemokinesIBA
01/2019
1Peptide Hydrolases (Proteases)FDA Link
01/2019
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2019
1CXCR4 Receptors (CXCR4 Receptor)IBA
01/2019
1SynucleinsIBA
11/2015
1((5Z)5- (1,3- benzodioxol- 5- yl)methylene- 2- phenylamino- 3,5- dihydro- 4H- imidazol- 4- one)IBA
03/2014
1Dyrk KinasesIBA
03/2014
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
03/2014
1Hormones (Hormone)IBA
10/2013
1Fatty Acids (Saturated Fatty Acids)IBA
07/2013
1Dihydrotachysterol (AT 10)IBA
07/2013
1Pharmaceutical PreparationsIBA
09/2009
1Tyrosine (L-Tyrosine)FDA Link
10/2007
1Antigen-Antibody Complex (Immune Complex)IBA
10/2007
1LigandsIBA
10/2007
11-Phosphatidylinositol 4-Kinase (1 Phosphatidylinositol 4 Kinase)IBA
10/2007
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2007
1ErbB Receptors (EGF Receptor)IBA
10/2007
1Heparin-binding EGF-like Growth Factor (HB-EGF)IBA
10/2007
1myotubularinIBA
04/2004
1GlucosyltransferasesIBA
04/2004
1P-2 (P 2)IBA
04/2004
1GTP Phosphohydrolase ActivatorsIBA
04/2004
1Endothelin-1 (Endothelin 1)IBA
09/2003

Therapy/Procedure

1Therapeutics
11/2019
1Mastectomy (Mammectomy)
10/2013